Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
Impact China II
Pharmaceutical R&D Global Summit
| Type | Conference |
|---|---|
| Language | English |
| Date |
May 21, 2006
to May 24, 2006 |
| Venue |
Shangri-La Hotel 29 Zizhuyuan Road Beijing, 100089 CN |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Jon Liong Strategic Research Institute 333 Seventh Avenue New York, NY 10001 US 212-967-0095 212-967-7973 jliong@srinstitute.com |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
The growing impact that China is having on the global pharmaceutical marketplace is currently being felt by the industry on a wide scale in areas such as outsourcing, clinical trials, manufacturing and more recently, drug discovery and development. But what should the industry realistically expect from their investments in China in the coming years? Impact China II will separate the Hype vs. Reality surrounding the Chinese market by providing attendees an unbiased look into the current state of the industry. We have doubled the number of speakers to over 75, each of who will give their “on-the-ground” views addressing timely and pressing issues.
Speakers
Featured Keynote Speakers:
Wang Baoping, Ph.D.
Research Director
NOVO NORDISK CHINA
Lorenz Ng, M.D., Ph.D.
Vice President, Research Alliance & Business Development, Asia Pacific
ELI LILLY ASIA
Steven J. Projan, Ph.D.
Vice President & Head Biological Technologies
WYETH RESEARCH
Ming-De Yu
Executive Chairman of the Board
CHINA WORLDBEST LIFE INDUSTRY CO.
Huacheng Wei, M.B.A.
Chairman of the Board
BEIJING PHARMACEUTICAL GROUP
Jing Cheng, Ph.D.
Chief Executive Officer
CAPITALBIO CORP.
Lee E. Babiss, Ph.D.
Vice President, Preclinical R&D
HOFFMAN-LA ROCHE
Other topics
Outsourcing, clinical trials